BB

BB Biotech Portfolio holdings

AUM $3.98B
This Quarter Return
-1.39%
1 Year Return
+15.06%
3 Year Return
+120.36%
5 Year Return
+263.74%
10 Year Return
AUM
$2.7B
AUM Growth
+$2.7B
Cap. Flow
+$13.8M
Cap. Flow %
0.51%
Top 10 Hldgs %
78.13%
Holding
30
New
1
Increased
8
Reduced
2
Closed
1
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
CELG
1
DELISTED
Celgene Corp
CELG
$400M 14.83%
3,459,298
INCY icon
2
Incyte
INCY
$16.5B
$389M 14.41%
3,879,822
IONS icon
3
Ionis Pharmaceuticals
IONS
$6.79B
$331M 12.25%
6,913,172
-250,000
-3% -$12M
GILD icon
4
Gilead Sciences
GILD
$140B
$199M 7.36%
2,774,596
RDUS
5
DELISTED
Radius Health, Inc.
RDUS
$166M 6.14%
4,360,399
ALXN
6
DELISTED
Alexion Pharmaceuticals Inc
ALXN
$150M 5.57%
1,229,428
+50,000
+4% +$6.12M
TSRO
7
DELISTED
TESARO, Inc.
TSRO
$131M 4.85%
974,582
NBIX icon
8
Neurocrine Biosciences
NBIX
$13.8B
$122M 4.52%
3,151,552
+30,000
+1% +$1.16M
AGIO icon
9
Agios Pharmaceuticals
AGIO
$2.19B
$117M 4.34%
2,809,528
+160,000
+6% +$6.68M
VRTX icon
10
Vertex Pharmaceuticals
VRTX
$100B
$104M 3.86%
1,415,445
REGN icon
11
Regeneron Pharmaceuticals
REGN
$61.5B
$89.9M 3.33%
245,000
HALO icon
12
Halozyme
HALO
$8.56B
$75.1M 2.78%
7,599,832
+220,000
+3% +$2.17M
SAGE
13
DELISTED
Sage Therapeutics
SAGE
$52.2M 1.93%
1,022,439
ALNY icon
14
Alnylam Pharmaceuticals
ALNY
$58.5B
$44.6M 1.65%
1,191,338
MYOV
15
DELISTED
Myovant Sciences Ltd.
MYOV
$39.7M 1.47%
+3,192,835
New +$39.7M
MGNX icon
16
MacroGenics
MGNX
$112M
$39.2M 1.45%
1,920,000
+465,000
+32% +$9.5M
KITE
17
DELISTED
Kite Pharma, Inc.
KITE
$35.9M 1.33%
800,000
JUNO
18
DELISTED
Juno Therapeutics, Inc.
JUNO
$35.3M 1.31%
1,870,000
+465,000
+33% +$8.77M
ALDR
19
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
$35.1M 1.3%
1,685,150
ICPT
20
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$27.8M 1.03%
255,719
ITCI
21
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$23.8M 0.88%
1,575,000
+225,000
+17% +$3.4M
PRTA icon
22
Prothena Corp
PRTA
$441M
$17.2M 0.64%
350,000
AVXS
23
DELISTED
AveXis, Inc. Common Stock
AVXS
$16.8M 0.62%
352,800
ESPR icon
24
Esperion Therapeutics
ESPR
$448M
$16.4M 0.61%
1,308,542
CDTX icon
25
Cidara Therapeutics
CDTX
$1.66B
$10.9M 0.4%
1,043,824
+297,000
+40% +$3.09M